이지템
2 known investors
EasyTEM is a manufacturer that originated from medical-device technology patents and expanded into home-use beauty devices, handling research, development, and production as a connected process. It positions itself as a manufacturer that supports products from development through manufacturing and export.
Also known as (주)이지템 · EasyTEM · 이지템
Investors · 2
Company profile
researched Aug 2026이지템 ((주)이지템, EasyTEM) is a South Korean developer and manufacturer of beauty and healthcare devices, incorporated on 20 August 2008 and headquartered in the Prime Castle knowledge-industry center in Sincheon-dong, Siheung, Gyeonggi Province. Its registered line of business is the manufacture, wholesale/retail and e-commerce distribution of medical devices, specifically infrared thermometers and skin-beauty devices, and it is classified under "other medical instrument manufacturing." The company is a small-and-medium enterprise, an export-import business, and a certified military-service-exception employer, with 73 employees on national pension records. 이해욱 (Lee Hae-wook) is the representative director.
The company offers three defined collaboration models to brand customers: ODM, covering product direction-setting through development and mass production; White Label, using already-validated products to shorten lead times; and OEM, covering volume production and quality control against partner specifications. It describes an integrated execution framework in which planning, design, development, mass production and quality management are all handled inside one organization, with each stage able to run independently depending on the scope a client requires. Its public performance headings cover cumulative supply volume, annual production capacity, project count and patents.
Technology work is organized around an in-house research function, with a Sensor Technology Research Institute established in February 2010. Reported core technologies include arcporation (AP) and electroporation (EP) applied to skin-beauty equipment, plus a professional-use aesthetic multi-function skin device called Cellizer.
Business model
이지템 develops and manufactures beauty and healthcare devices for other brands under ODM, OEM and White Label arrangements, and also handles wholesale/retail and e-commerce distribution of medical devices such as infrared thermometers and skin-beauty equipment. Clients choose the scope of engagement — full product direction-setting and development through mass production (ODM), faster-turnaround development on validated existing products (White Label), or production and quality control to partner specifications (OEM). The company has said it planned to build an ODM one-stop service so that major customers can concentrate on domestic and overseas sales.
Revenue comes from contract development and manufacturing of devices for brand customers plus sales of its own medical and beauty devices. 2023 revenue was reported at KRW 35 billion, of which more than 90% came from beauty devices; the 2024 targets cited were KRW 50 billion in revenue and KRW 6 billion in operating profit.
Traction
2023 revenue was reported at KRW 35 billion with over 90% from beauty devices, and beauty-device production volume roughly doubled year over year on domestic ODM/OEM expansion. The company developed and supplied the Medicube AGE-R ATS Air Shot device, which gained public attention as the "Kim Hee-sun device." It raised KRW 17.5 billion from five venture capital firms in February 2024, signed Daishin Securities as lead underwriter for a KOSDAQ listing in April 2024, and won the Minister of SMEs and Startups award as the winning team at L'Oréal's Big Bang Open Innovation program in November 2023.
Latest developments
In February 2024 이지템 raised a total of KRW 17.5 billion from five venture capital firms, allocating proceeds to development of the professional beauty device Cellizer, increased R&D capability, new-business infrastructure, and IPO preparation. In April 2024 it contracted Daishin Securities as lead underwriter for a KOSDAQ listing, with press reports expecting listing in the second half of 2024. The same year it expanded ODM facilities and services and published its arcporation research as the June 2024 cover paper of the Journal of Cosmetic Dermatology.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Coverage describes 이지템 as a leading Korean home-care beauty device specialist and the top domestic ODM operator in its segment, with expansion into overseas markets. Domestic ODM/OEM growth reportedly doubled its beauty-device output in 2023 versus the prior year, and more than 90% of its 2023 revenue came from beauty devices.
The company positions the ability to run planning, design, development, mass production and quality control within a single organizational structure, letting customers select only the stages they need across ODM, OEM and White Label models. It also points to proprietary skin-delivery technologies (arcporation and electroporation) validated in a peer-reviewed dermatology journal, medical-device origins including infrared thermometers, KGMP and NET certifications, and an in-house sensor research institute.
Technology
이지템 established an in-house Sensor Technology Research Institute in 2010 and cites arcporation (AP) and electroporation (EP) as core technologies for skin-beauty devices, alongside a professional aesthetic multi-function device, Cellizer. It published a paper on applying arcporation to skin-beauty equipment to improve cosmetic-ingredient skin absorption, which ran as the cover paper of the June 2024 issue of the US journal Journal of Cosmetic Dermatology. The company received New Excellent Technology (NET) certification from the Ministry of Trade, Industry and Energy in August 2014 and KGMP medical-device manufacturing and quality-management conformity certification in November 2011. Its published performance metrics include a patent portfolio count.
Go-to-market
Domestic and overseas beauty and healthcare brands that need a development and manufacturing partner for home-care and professional skin-beauty devices, including cosmetics-linked device brands such as Medicube (메디큐브 에이지알 ATS 에어샷 was developed and supplied by 이지템). End products also reach consumers through medical-device retail and e-commerce channels.
Geography
Headquarters and operations are in Siheung, Gyeonggi Province, South Korea (Poddowon-ro 116beon-gil 25, Room 304, Sincheon-dong, Prime Castle Knowledge Industry Center). The company is registered as an export-import business, operates a bilingual Korean/English website, and reported entry into overseas markets alongside its domestic ODM business.
History
이지템 was founded on 20 August 2008. It set up an affiliated Sensor Technology Research Institute in February 2010, obtained KGMP medical-device manufacturing and quality-management certification in November 2011, received New Excellent Technology (NET) certification from the Ministry of Trade, Industry and Energy in August 2014, and won the IR52 Jang Young-shil Award for a facial thermometer in April 2015. In July 2020 it relocated its head office after purchasing its own building (Eunhaeng-dong to Sincheon-dong). In November 2023 it was selected as the winning team at L'Oréal's Big Bang Open Innovation program. In February 2024 it raised KRW 17.5 billion from five venture capital firms, and in April 2024 it signed Daishin Securities as lead underwriter for a planned KOSDAQ listing, which press reports at the time expected in the second half of 2024.
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 11
launches, deals, and filingsA paper on applying arcporation to skin-beauty devices to improve cosmetic absorption into skin was published as the cover paper of the June 2024 issue of the US journal Journal of Cosmetic Dermatology.
The company signed a lead-underwriting agreement with Daishin Securities in April 2024 to prepare a KOSDAQ listing, which press reports expected in the second half of 2024.
이지템 attracted a total of KRW 17.5 billion in investment from five venture capital firms; proceeds were directed to development of the professional beauty device Cellizer, expanded R&D, new-business infrastructure and IPO preparation.
이지템 developed and supplied the Medicube AGE-R ATS Air Shot device incorporating its arcporation technology; it became widely known as the "Kim Hee-sun device."
Selected as the winning team at L'Oréal's global startup program with its arcporation (AP) and electroporation (EP) technologies and the Cellizer aesthetic multi-function skin device, receiving the Minister of SMEs and Startups award.
Head office moved from Eunhaeng-dong to Sincheon-dong following the purchase of the company's own building.
Certification of conformity with medical-device manufacturing and quality-management standards (KFDA, KTL-AB-110285).
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 5
primary sources listed
- 이지템easytem.co.kr · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does 이지템 do?
- Korean manufacturer of home-care beauty devices and medical thermometers, working as an ODM/OEM/White Label partner.
- Who are 이지템's investors?
- 이지템's investors include Laguna Investment, We Ventures.